Has Mark Dacey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,271 in general payments to Mark Dacey, MD across 30 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Dacey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Dacey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Dacey, MD

Ophthalmology · East Weymouth, MANPI 1184613192

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $14,800 of the $17,271 with a category attached, or 85.7%. ANI Pharmaceuticals, Inc. accounts for 97.2% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $16,782, more than ten times the $79 reported in 2019. Among ophthalmology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,271in general payments, 2019–2025

Across 30 payments — averaging $575.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ANI Pharmaceuticals, Inc.$17K
Regeneron Healthcare Solutions, Inc.$288
Alimera Sciences, Inc.$201

What the payments were for

Speaking & faculty fees$14,80086%
Travel & lodging$1,73810%
Food & beverage$7064%
Education$260%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ANI Pharmaceuticals, Inc.	13	$16,782
Regeneron Healthcare Solutions, Inc.	15	$288
Alimera Sciences, Inc.	2	$201

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,271 in reported general payments places this provider in the 90th percentile of 653 ophthalmology providers in Massachusetts.

See all ophthalmology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$3,285,021

Medicare patients

2,065

Services billed

21,049

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	153	$5,034
Atropine Sulfate	69	$1,578
Ofloxacin	72	$683
Brimonidine Tartrate	44	$370
Latanoprost	33	$365
ErythromycinErythromycin Base	12	$126

Paid to pharmacies, not to this prescriber.

Other ophthalmology in East Weymouth

James StefaterEast Weymouth$19K
Rishi SinghBoston$1.7M
Peter ChangWaltham$992K
Stephen AnesiWaltham$922K
David LallySpringfield$328K
Adam RogersBoston$316K
Bonnie HendersonBoston$279K
Mark LatinaReading$279K
Dean EliottBoston$250K
Jeremy KievalLexington$232K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →